Paper Details
- Home
- Paper Details
Progress in study on the association between HLA genetic variation and adverse drug reactions.
Author: LiuYating, OuyangDongsheng, ZengXiangchang
Original Abstract of the Article :
The human leukocyte antigen (HLA) molecules encoded within the human major histocompatibility complex are a group of highly conserved cell surface proteins, which are related to antigen recognition. HLA genes display a high degree of genetic polymorphism, which is the basis of individual differences...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.11817/j.issn.1672-7347.2021.200256
データ提供:米国国立医学図書館(NLM)
HLA Genetic Variation and Adverse Drug Reactions: A Growing Area of Research
The field of pharmacogenetics is rapidly evolving, seeking to understand the intricate interplay between individual genetic variations and drug responses. This research explores the association between HLA genetic variation, a key component of our immune system, and adverse drug reactions (ADRs). The researchers reviewed the existing literature to identify specific HLA genotypes associated with various ADRs, including severe cutaneous reactions, drug-induced hypersensitivity syndrome, and liver injury. This research aims to provide an overview of the current understanding of the relationship between HLA genetic variations and the risk of developing ADRs. This study reviewed published studies to understand the relationship between HLA genetic variation and ADRs.
HLA: A Potential Biomarker for Predicting Adverse Drug Reactions
The review highlighted a strong association between specific HLA genotypes and various ADRs. This suggests that HLA genetic variation could serve as a potential biomarker for predicting ADR risk in individuals. This finding has significant implications for personalized medicine, allowing for more tailored treatment approaches based on individual genetic profiles. This research emphasizes the need for further research to validate these findings and develop more effective strategies for minimizing ADRs.
Understanding Individual Differences in Drug Responses: A Step Towards Safer Treatment
The study's findings underscore the importance of understanding individual differences in drug responses. By incorporating HLA genetic information into clinical practice, we can potentially identify individuals at higher risk of developing ADRs. This knowledge could lead to preventive measures, dose adjustments, or alternative treatment options, ultimately improving the safety and efficacy of drug therapy.
Dr.Camel's Conclusion
Just as the desert landscape is shaped by the forces of nature, our genetic makeup influences our response to medications. This review delves into the fascinating relationship between HLA genes and adverse drug reactions, highlighting the potential for personalized medicine to improve drug safety. By understanding the intricate interplay between genetics and drug responses, we can navigate the desert of medication effects with greater precision and care.
Date :
- Date Completed 2021-05-11
- Date Revised 2021-05-11
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.